• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acceleron Pharma Inc

+ Add to Watchlist

XLRN:US

24.9200 USD 0.7100 2.93%

As of 17:20:00 ET on 09/22/2014.

Snapshot for Acceleron Pharma Inc (XLRN)

Open: 24.1900 Day's Range: 23.8700 - 25.0400 Volume: 113,049
Previous Close: 24.2100 52wk Range: 16.7800 - 57.8900 1-Yr Rtn: +18.72%

Stock Chart for XLRN

No chart data available.
  • XLRN:US 24.9799
  • 1D
  • 1M
  • 1Y
24.2100
Interactive XLRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XLRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -6.9815
Est. EPS (USD) (12/2014) -1.4300
Est. PEG Ratio -
Market Cap (M USD) 794.29
Shares Outstanding (M) 31.80
30 Day Average Volume 151,007
Price/Book (mrq) 4.6549
Price/Sale (ttm) 15.4102
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XLRN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XLRN

Acceleron Pharma, Inc. provides pharmaceutical products. The Company focuses on discovering, developing, manufacturing, and marketing of protein therapeutics for cancer and orphan diseases. Acceleron Pharma serves patients throughout the United States.

John L KnopfPresident/CEO/Co-FounderKevin F McLaughlinSenior VP/CFO/Treasurer
Matthew L ShermanSenior VP/Chief Medical OfcrSteven ErtelSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for XLRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil